Double-blind, Placebo-controlled Clinical Trial of JK6476 (Risperidone) in Patients With Hallucinations and Delusions Associated With Alzheimer's Disease.
Phase of Trial: Phase III
Latest Information Update: 12 Nov 2010
At a glance
- Drugs Risperidone (Primary)
- Indications Alzheimer's disease
- Focus Therapeutic Use
- Sponsors Janssen
- 12 Nov 2010 Actual end date (Mar 2003) added as reported by ClinicalTrials.gov.
- 12 Nov 2010 Actual initiation date (Mar 2002) added as reported by ClinicalTrials.gov.
- 09 May 2008 Status changed from in progress to discontinued according to ClinicalTrials.gov.